A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
NCT03559803
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
DRUG:
Cisplatin
Sponsor
Sichuan University